The studies by Matsuzaki et al and Yamagata H et al also demonstrated that Smad3 signaling is shifted from tumor-suppression to oncogenesis in HCC and colorectal cancer [26, 35]; however, the molecular mechanisms have not been well characterized. This evidence concerns the gene SMAD3 and hepatocellular carcinoma.